metvix 160 mg/g creme
paranova danmark a/s - methylaminolevulinathydrochlorid - creme - 160 mg/g
valproat "life medical" 100 mg/ml injektions-/infusionsvæske, opløsning
life medical aps - natriumvalproat - injektions-/infusionsvæske, opløsning - 100 mg/ml
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
mektovi
pierre fabre medicament - binimetinib - melanom - antineoplastiske midler - binimetinib i kombination med encorafenib er indiceret til behandling af voksne patienter med inoperabel eller metastatisk melanom med en braf v600 mutation.
orfiril 60 mg/ml oral opløsning
2care4 aps - natriumvalproat - oral opløsning - 60 mg/ml
depakine chrono 500 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 500 mg
metvix 160 mg/g creme
paranova danmark a/s - methylaminolevulinathydrochlorid - creme - 160 mg/g
orfiril 60 mg/ml oral opløsning
medartuum ab - natriumvalproat - oral opløsning - 60 mg/ml